Hypertension among older adults in low- and middle-income countries: prevalence, awareness and control.

Lloyd-Sherlock P, Beard J, Minicuci N, Ebrahim S, Chatterji S. · 2014

Read Hypertension among older adults in low- and middle-income countries: prevalence, awareness and control. by Lloyd-Sherlock P, Beard J, Minicuci N, Ebrahim S, Chatterji S. (2014) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3937973.txt.

Introduction

Peter Lloyd-Sherlock, John Beard, Nadia Minicuci, Shah Ebrahim, and Somnath Chatterji measure high blood pressure in older adults across six poorer and middle-income countries in the International Journal of Epidemiology in 2014. Their data come from the World Health Organization's SAGE study of ageing, covering 35,125 randomly selected people aged 50 and over in China, Ghana, India, Mexico, Russia, and South Africa.

Overall prevalence was 52.9 percent, as high as in rich countries, ranging from 32.3 percent in India to 77.9 percent in South Africa. Yet awareness was low: fewer than half knew their condition, and only about one in ten had it controlled, with treatment success at about a quarter of those treated. Being overweight, female, poorer, or a heavy drinker raised the odds. The authors urge new approaches to a major killer.

Catalog record

CREATORLloyd-Sherlock P, Beard J, Minicuci N, Ebrahim S, Chatterji S.
YEAR2014
COLLECTIONPAPERS
FORMATTXT
FILE SIZE37 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC3937973

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Hypertension among older adults in low- and middle-income countries: prevalence, awareness and control By Peter Lloyd-Sherlock, John Beard, Nadia Minicuci, Shah Ebrahim, Somnath Chatterji Published in: International Journal of Epidemiology DOI: 10.1093/ije/dyt215 ABSTRACT Abstract Background This study uses data from the World Health Organization’s Study on Global Ageing and Adult Health (SAGE) to examine patterns of hypertension prevalence, awareness, treatment and control for people aged 50 years and over in China, Ghana, India, Mexico, the Russian Federation and South Africa. Methods The SAGE sample comprises of 35 125 people aged 50 years and older, selected randomly. Hypertension was defined as ≥140 mmHg (systolic blood pressure) or ≥90 mmHg (diastolic blood pressure) or by currently taking antihypertensives. Control of hypertension was defined as blood pressure below 140/90 mmHg on treatment. A person was defined as aware if he/she was hypertensive and self-reported the condition. Results Prevalence rates in all countries are broadly comparable to those of developed countries (52.9%; range 32.3% in India to 77.9% in South Africa). Hypertension was associated with overweight/obesity and was more common in women, those in the lowest wealth quintile and in heavy alcohol consumers. Awareness was found to be low for all countries, albeit with substantial national variations (48.3%; range 23.3% in Ghana to 72.1% in the Russian Federation). This was also the case for control (10.2%; range 4.1% in Ghana to 14.1% India) and treatment efficacy (26.3%; range 17.4% in the Russian Federation to 55.2% in India). Awareness was associated with increasing age, being female and being overweight or obese. Effective control of hypertension was more likely in older people, women and in the richest quintile. Obesity was associated with poorer control. Conclusions The high rates of hypertension in low- and middle-income countries are striking. Levels of treatment and control are inadequate despite half those sampled being aware of their condition. Since cardiovascular disease is by far the largest cause of years of life lost in these settings, these findings emphasize the need for new approaches towards control of this major risk factor. Keywords: Hypertension, older people, risk factors, developing countries INTRODUCTION Populations around the world are rapidly ageing, and low- and middle-income countries (LMICS) are experiencing some of the most dramatic increases.1 This demographic transition is closely linked to an epidemiological shift from communicable to non-communicable disease (NCD).2 Hypertension, a key NCD risk factor, appears to be increasing in prevalence, possibly associated with development, urbanization and lifestyle changes.2,3 However, there are large variations in reported prevalence, both across and within countries.4,5 This is particularly apparent in LMICs, although these discrepancies may be partly due to variations in survey design and measurement. Systematically verifying the extent of these national and sub-national variations using directly measured blood pressure, and identifying potentially modifiable causes, may facilitate the development of interventions to slow the rise in NCD occurrence. Systematic analysis is also needed to assess the degree to which hypertension is detected, treated and controlled, and assess social gradients for all these aspects of hypertension. Hypertension prevalence increases with age, and is a readily treatable risk factor for the most common causes of morbidity and mortality in older age: stroke, ischaemic heart disease, renal insufficiency and dementia.6–8 It has been suggested that the burden of stroke and ischaemic heart disease may be several times higher in LMICs than in their high-income counterparts.2 Yet, whereas LMICs are experiencing the most rapid population ageing, our understanding of the prevalence and management of hypertension in these settings remains limited. Although there is some evidence of high prevalence in LMICs9–11 these studies are small, do not always include older participants, and little is concluded about the awareness of hypertension, the extent of effective or ineffective treatment, or the factors that might influence awareness or treatment in these settings. To fill this crucial gap in our understanding, this study examines the prevalence and possible determinants of hypertension and effective treatment in representative samples of over 35 000 older people in low- and middle-income settings. METHODS We use new publicly available data from the World Health Organization (WHO) Study on Global Aging and Adult Health (SAGE). This comprises nationally representative household surveys in China, Ghana, India, Mexico, South Africa and the Russian Federation. Respondents were selected using a multi-stage, stratified, random cluster sampling design with every individual having a known non-zero probability of being selected. The primary sampling units were stratified by region and location (urban/rural) and, within each stratum, enumeration areas were selected. Details are available on the SAGE website (www.who.int/healthinfo/systems/sage). The six countries comprise a total study population of 35 125 people aged 50 years and over. The period of data collection varied by country, ranging between 2007 and 2010. Overall individual response rates among those eligible within households and agreeing to participate in the survey varied from 52.4% in Mexico to 92.3% in China (Table 1). Supplementary Table A1 (available as Supplementary data at IJE online) provides more detailed information about response rates to different questionnaire items. Ethical clearance was obtained from local research review boards at each participating SAGE site and the WHO Ethical Review Committee. Informed consent was obtained from each respondent prior to interview. Further information about the SAGE survey design and methods is available from a published data resource profile.12 [Table: Distribution (%) of characteristics, overall and by country] Blood pressure (BP) was measured using a Boso Medistar Wrist Blood Pressure Monitor Model S. Validation studies of similar wrist blood pressure monitoring devices indicate that they are capable of providing accurate measurements13,14 but that the position of the arm in relation to the heart is critical (http://www.bhsoc.org/bp-monitors/bp-monitors/). Respondents were asked to remain seated and relaxed, and the importance of positioning their arm level with their heart was emphasized. BP was measured three times, with 1 min between each measurement. Participants were asked to self-report: ‘Have you ever been diagnosed with high BP (hypertension)?’ Those answering ‘yes’ were further asked: ‘Have you been taking any medications or other treatment for it during a) the last 2 weeks? b) the last 12 months?’ Height was measured using a stadiometer and weight was measured using an electronic weighing scale that was periodically calibrated. All interviewers were provided with a week of training, including demonstrations and audiovisual aids. Before launching the main phase of the study, a pretest was carried out on 1446 respondents, with 5% of respondents being retested within 7 days with an identical instrument. The SAGE main study also included a retest component on 5% of respondents. These studies show a moderate reliability in these measures with trained lay interviewers (kappa for obesity 0.8; for hypertension 0.5). Hypertension was considered to be present if the mean of the last two measurements was ≥140 mmHg (systolic blood pressure) or ≥90 mmHg (diastolic blood pressure) or if respondents were currently taking antihypertensives. Hypertensive participants were classified as controlled (i.e. on antihypertensives and blood pressure <140 or <90 mmHg). Those who were aware of their hypertension were classified into controlled and uncontrolled. Finally, among all those who were currently on treatment for hypertension, respondents were classified into those who were effectively treated (normotensive on measurement) and those who were not effectively treated (hypertensive on measurement). All data analysis was weighted,

Read the complete text